Global and regional trends in Clostridioides difficile infection: an analysis from 1990 to 2021.|https://dx.doi.org/10.1016/j.jgar.2025.04.001
Racial Disparities in Utilization of Medications and Disease Outcomes in Inflammatory Bowel Disease Patients.|https://dx.doi.org/10.1093/crocol/otaf021
Two decades of experience of the Fabry Outcome Survey provides further confirmation of the long-term effectiveness of agalsidase alfa enzyme replacement therapy.|https://dx.doi.org/10.1016/j.ymgmr.2025.101215
